In a number of weekly updates revealed right now, the US Facilities for Illness Management and Prevention (CDC) mentioned seasonal influenza and RSV (respiratory syncytial virus) exercise are low nationally, and COVID-19 exercise is elevated however declining.
The test-positivity share for COVID-19 dropped to 11.6% final week from 13.4 % the prior week, in response to the weekly replace for the week ending on September 21.
Different COVID indicators declined as effectively, however solely barely. Emergency division visits dropped from 1.7% to 1.4%, and hospitalizations per 100,000 inhabitants dropped to 4.0, down from the prior week’s 4.1. In its biweekly variant replace, the CDC famous that the KP.3.1.1 Omicron subvariant accounts for 52.7% of infections, the identical as 2 weeks in the past.
Wastewater ranges for COVID-19 stay excessive however low for RSV and influenza. Of flu instances recognized via specimens testing, the H1N1 pressure accounts for 53.5% of instances, H3N2 for 46.5%, and influenza B for 1.2%. Influenza check positivity for the week ending on September 21 was 0.6%.
Outpatient respiratory sickness visits additionally remained regular, at 1.9%.
Of notice, the CDC recorded no new human infections with novel influenza A viruses, with the season’s whole remaining at 23.
Very low vaccine uptake
Based on the CDC, the early weeks of flu vaccine availability have resulted in 9.6% adults reporting receipt of a flu vaccine and 4.5% of adults reporting receipt of the up to date 2024-25 COVID-19 vaccine
Amongst adults 75 years and older, 34.0% reported ever receiving an RSV vaccine.
